Top Markets
Coin of the day
Photocure ASA Photocure ASA

Photocure ASA

PHO
Rangering i aksjer #19788
Photocure ASA is a specialized pharmaceutical enterprise focused on the... Photocure ASA is a specialized pharmaceutical enterprise focused on the development, manufacturing, commercialization, and distribution of medicinal products. Its operational footprint extends across multiple European nations, including the Nordic region, Germany, France, Austria, the United Kingdom, the Netherlands, and Italy, in addition to the United States. The company's primary offering, Hexvix/Cysview, aids in the identification and ongoing management of bladder cancer. Moreover, Photocure is actively progressing Cevira, a therapeutic agent in development targeting human papilloma virus (HPV) infections and pre-cancerous lesions of the cervix. The firm distributes its products to pharmaceutical wholesalers, pharmacies, and healthcare institutions through collaborative licensing arrangements. Founded in 1993, Photocure ASA maintains its corporate headquarters in Oslo, Norway.
Aksjekurs
$5.66
Sist synkronisert: 2026-08-25
Markedsverdi
$150.59M
Endring (1 dag)
0.00%
Endring (1 år)
-7.22%
Land
NO
Handel Photocure ASA (PHO)

Kategori

EPS for Photocure ASA (PHO)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Photocure ASA er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Photocure ASA fra 2026 til 2026
EPS ved slutten av hvert år
År EPS Endre
Ikke nok data for de angitte datoene.
EPS for lignende selskaper eller konkurrenter
Selskap EPS EPS-forskjell Land
$17.32 -
US
$27.74 -
NL
$-7.98 -
US
$-5.29 -
AU
- -
CH